[VYNE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -6.83%
YoY- 13.87%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 126 178 2,292 4,086 4,258 4,119 4,286 -90.53%
PBT -8,235 -8,694 -12,018 -21,285 -19,924 -20,550 -23,181 -49.93%
Tax 241 -13,364 -448 3,439 1,005 1,005 -258 -
NP -8,476 4,670 -11,570 -21,285 -19,924 -20,550 -23,181 -48.96%
Tax Rate - - - - - - - -
Total Cost 8,602 -4,492 13,862 25,371 24,182 24,669 27,467 -53.98%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -6,726.98 2,623.60 -504.80 -520.93 -467.92 -498.91 -540.85 439.30%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -2.63 1.52 -3.89 -7.36 -6.98 -7.57 -8.54 -54.49%
EPS Diluted -2.63 1.52 -3.89 -7.36 -6.98 -7.57 -8.54 -54.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.